- Open
- 1.03
- High
- 1.03
- Low
- 0.95
- Close
- 1.02
- Change
- -0.08 (-7.84%)
- Volume
- 163,277
⌘K
| 16 Apr 2026 | 12:37:09 | Holding(s) in Company |
| 31 Dec 2025 | 08:22:03 | Half-year Financial Report |
| 21 Nov 2025 | 13:38:17 | Result of AGM |
| 30 Oct 2025 | 07:30:01 | Restoration - Provexis plc |
| 11 Oct 2024 | Annual Report and Accounts (to 2024-03-31) | |
| 13 Oct 2023 | Annual Report and Accounts (to 2023-03-31) | |
| 10 Oct 2022 | Annual Report and Accounts (to 2022-03-31) |
Provexis Limited is a company that aims to bring to market the Fruitflow® anti-thrombotic technology, which was developed by Professor Asim Duttaroy at the Rowett Research Institute.
| 16 Apr 2026 | 12:37:09 | Holding(s) in Company |
| 31 Dec 2025 | 08:22:03 | Half-year Financial Report |
| 21 Nov 2025 | 13:38:17 | Result of AGM |
| 30 Oct 2025 | 07:30:01 | Restoration - Provexis plc |
| 11 Oct 2024 | Annual Report and Accounts (to 2024-03-31) | |
| 13 Oct 2023 | Annual Report and Accounts (to 2023-03-31) | |
| 10 Oct 2022 | Annual Report and Accounts (to 2022-03-31) |
Provexis Limited is a company that aims to bring to market the Fruitflow® anti-thrombotic technology, which was developed by Professor Asim Duttaroy at the Rowett Research Institute.
| 30 Oct 2025 |
| 07:00:11 |
| Final Results |
| 30 Oct 2025 |
| 07:00:11 |
| Final Results |